Ignite Creation Date:
2024-05-06 @ 12:59 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03900949
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2019-04-01
Brief Title:
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia
Sponsor:
Organization:
Ohio State University Comprehensive Cancer Center